Antitrust Antitrust

Indian government directed to invoke compulsory licensing for drugs to treat Covid-19 patients

By Freny Patel
  • 27 Apr 2021 04:56
  • 27 Apr 2021 04:56
As India battles a second wave of the Covid-19 pandemic and faces a shortage of life-saving drugs, the Delhi High Court has directed the government to invoke its powers of compulsory licensing under the Patent Act if all else fails.
Compulsory licensing enables a government to allow a third party

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Freny Patel


Freny has been covering antitrust law, M&A and regulations for over a decade, serving as Asia editor at Policy and Regulatory Report. Prior to joining as an editor at Mergermarket, she headed the banking bureau of a leading Indian financial daily, Business Standard. When India privatized the insurance sector, she had her own column in The Observer.

Discover MLex

Stay on top of global regulatory developments

Latest News